Detalles de la búsqueda
1.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Oncologist;
2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520745
2.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist;
27(2): 87-e115, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641222
3.
Immunotherapy in NSCLC Patients with Brain Metastases.
Int J Mol Sci;
23(13)2022 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35806080
4.
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic.
Oncologist;
26(4): e694-e703, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539583
5.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother;
69(11): 2209-2221, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474768
6.
Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational Study.
Cancers (Basel);
16(1)2023 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201603
7.
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Eur J Cancer;
187: 25-35, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099946
8.
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature.
Curr Oncol;
29(12): 9630-9639, 2022 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36547170
9.
Multidisciplinary Approach to Patients With Metastatic Spinal Cord Compression: A Diagnostic Therapeutic Algorithm to Improve the Neurological Outcome.
Front Oncol;
12: 902928, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747823
10.
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
Front Oncol;
12: 885992, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747814
11.
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review.
Cells;
10(6)2021 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34071228
12.
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology).
J Neurol;
268(8): 2866-2875, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33609154
13.
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Eur J Cancer;
148: 24-35, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721704
14.
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.
Front Oncol;
10: 550185, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33072577
15.
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation.
J Immunother Cancer;
8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077515
Resultados
1 -
15
de 15
1
Próxima >
>>